comparemela.com

Latest Breaking News On - Host disease - Page 7 : comparemela.com

Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial

Cynata Therapeutics Ltd (ASX:CYP) CEO Dr Kilian Kelly speaks with Proactive soon after announcing the company has initiated the first site in the USA in its.

Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting

BOSTON, Nov. 04, 2023 Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today shared new data on the impact of the company’s proprietary nicotinamide .

Gamida Cell Presents New Data on Allogeneic Stem Cell

Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa

BOSTON, October 02, 2023 Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that Abbey Jenkins, President and Chief Executive Officer, will present its corporate highlights at the annual Cell & Gene Meeting on the Mesa to be held October 10-12 in Carlsbad, California, and livestreamed globally. Ms. Jenkins will also participate in a panel titled "A record setting year for cell and gene therapies – how do we keep the momentum

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.